Watchlist Price Alert

MERCK Kommanditgesellscha... (MKKGY)

PNK: MKKGY · Real-Time Price · USD

26.29

-0.07 (-0.27%)

At close: Jun 02, 2025, 10:19 AM

-0.27% (1D)

Bid	26.29
Market Cap	56.98B
Revenue (ttm)	21.16B
Net Income (ttm)	2.78B
EPS (ttm)	1.46
PE Ratio (ttm)	18.01
Forward PE	12.51
Analyst	n/a

Ask	26.39
Volume	19,620
Avg. Volume (20D)	129,139
Open	26.26
Previous Close	26.36
Day's Range	26.13 - 26.39
52-Week Range	24.32 - 39.17
Beta	0.64

About MKKGY

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol MKKGY

Website n/a

Full Company Profile

News

2 weeks ago · seekingalpha.com

Merck KGaA (MKGAF) Q1 2025 Earnings Call Transcript

Merck KGaA (OTCPK:MKGAF) Q1 2025 Earnings Call May 15, 2025 8:00 AM ET Company Participants Florian Schraeder - Head, Investor Relations Belen Garijo - Group Chief Executive Officer Helene von Roeder ...

2 weeks ago · reuters.com

Germany's Merck drops China surcharge on orders after US-China tariff deal

German healthcare and materials group Merck KGaA has dropped a surcharge on life sciences sector orders within China following the U.S.-China agreement to pause sky-high tariffs on each other, the com...

1 month ago · zacks.com

MKKGY vs. ZTS: Which Stock Is the Better Value Option?

Investors interested in stocks from the Medical - Drugs sector have probably already heard of Merck KGaA (MKKGY) and Zoetis (ZTS). But which of these two stocks offers value investors a better bang fo...

1 month ago · proactiveinvestors.co.uk

Merck KGaA swoops for US group SpringWorks in $3.4bn deal

Germany's Merck KGaA has agreed to acquire US biotech firm SpringWorks Therapeutics for $3.9 billion in cash. The deal, announced on Monday, values SpringWorks at $47 a share and reflects an enterpris...

1 month ago · wsj.com

Germany's Merck Set to Buy SpringWorks in $3.9 Billion Deal

The deal to acquire the U.S. biopharmaceutical company confirms an earlier report in The Wall Street Journal.

1 month ago · reuters.com

Germany's Merck KGaA in $3.9 bln deal to acquire US biotech firm SpringWorks

German healthcare and materials group Merck KGaA said on Monday it struck a deal to acquire U.S. biotech firm SpringWorks Therapeutics for an equity value of $3.9 billion to boost its cancer drug busi...

2 months ago · youtube.com

Resilience is part of our DNA, says Merck KGaA CEO

Belén Garijo, CEO of Merck KGaA, said the German pharmaceutical company has increased its readiness to deal with the ongoing geopolitical uncertainty, and is confident it will continue delivering prof...

2 months ago · seekingalpha.com

Merck KGaA (MKGAF) Q4 2024 Earnings Call Transcript

Merck KGaA (OTCPK:MKGAF) Q4 2024 Results Conference Call March 6, 2025 8:00 AM ET Company Participants Florian Schraeder - Head of Investor Relations Belen Garijo - Group CEO Helene von Roeder - Group...

2 months ago · reuters.com

Merck KGaA sees forex-adjusted earnings growth of up to 8% this year

Merck KGaA on Thursday forecast currency-adjusted operating earnings growth of up to 8%, helped by demand for semiconductor chemicals and for lab equipment in biotech drug production.